The closing price of ProQR Therapeutics N.V (NASDAQ: PRQR) was $2.29 for the day, down -3.79% from the previous closing price of $2.38. In other words, the price has decreased by -$0.0901 from its previous closing price. On the day, 106449 shares were traded.
Ratios:
Our analysis of PRQR’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.53. For the most recent quarter (mrq), Quick Ratio is recorded 3.54 and its Current Ratio is at 3.54. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.44.
On March 30, 2023, JMP Securities Upgraded its rating to Mkt Outperform which previously was Mkt Perform and also upped its target price recommendation from $1.50 to $5.
Cantor Fitzgerald Upgraded its Neutral to Overweight on December 22, 2022, whereas the target price for the stock was revised from $0.80 to $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRQR now has a Market Capitalization of 193.62M and an Enterprise Value of 86.18M. For the stock, the TTM Price-to-Sale (P/S) ratio is 26.29 while its Price-to-Book (P/B) ratio in mrq is 3.93. Its current Enterprise Value per Revenue stands at 13.23 whereas that against EBITDA is -3.58.
Stock Price History:
The Beta on a monthly basis for PRQR is 0.21, which has changed by 7.51% over the last 52 weeks, in comparison to a change of 27.86% over the same period for the S&P500. Over the past 52 weeks, PRQR has reached a high of $3.65, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 2.1346, while the 200-Day Moving Average is calculated to be 1.7412.
Shares Statistics:
PRQR traded an average of 310.37K shares per day over the past three months and 179.51k shares per day over the past ten days. A total of 78.46M shares are outstanding, with a floating share count of 51.89M. Insiders hold about 35.79% of the company’s shares, while institutions hold 23.67% stake in the company. Shares short for PRQR as of Mar 15, 2024 were 272.13k with a Short Ratio of 0.88, compared to 319.01k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.33% and a Short% of Float of 0.47%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.17, while EPS last year was -$0.12. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.06 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$0.31 and -$0.72 for the fiscal current year, implying an average EPS of -$0.44. EPS for the following year is -$0.5, with 4 analysts recommending between -$0.29 and -$0.78.
Revenue Estimates
Based on 3 analysts’ estimates, the company’s revenue will be $25.39M in the next fiscal year. The high estimate is $45.92M and the low estimate is $8.57M. The average revenue growth estimate for next year is up 61.00% from the average revenue estimate for this year.
